Palisade Bio Inc.

NASDAQ: PALI · Real-Time Price · USD
0.80
-0.01 (-1.84%)
At close: Aug 15, 2025, 9:59 AM

Palisade Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 250K n/a n/a
Cost of Revenue
3K 4K 167K 168K
Gross Profit
-3K 250K -167K -168K
Operating Income
-14.86M -13.07M -15.72M -11.74M
Interest Income
n/a n/a 13K 3.08M
Pretax Income
-14.44M -12.3M -14.26M -26.62M
Net Income
-14.44M -12.3M -14.26M -26.62M
Selling & General & Admin
5.8M 6.2M 8.76M 9.31M
Research & Development
9.06M 6.89M 6.55M 2.43M
Other Expenses
n/a 225K 158K n/a
Operating Expenses
14.86M 13.32M 15.14M 11.74M
Interest Expense
12K 15K 13K 2.4M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
14.86M 13.32M 15.31M 41.85M
Income Tax Expense
n/a n/a n/a 655K
Shares Outstanding (Basic)
1.42M 6.84M 880.1K 186.19K
Shares Outstanding (Diluted)
1.42M 456.01K 880.3K 186.96K
EPS (Basic)
-10.19 -27.01 -16.53 -173.93
EPS (Diluted)
-10.19 -27.01 -16.53 -145.87
EBITDA
-14.86M -12.28M -15.15M -24.05M
EBIT
-14.45M -12.29M -15.31M -24.22M
Depreciation & Amortization
-409K 4K 167K 168K